Abstract:Background: Traumatic brain injury (TBI) has become the most common cause of death and disability in persons between 15 and 30 years of age, and about 10-15% of patients affected by TBI will end up in a coma. Coma caused by TBI presents a significant challenge to neuroscientists. Right median nerve electrical stimulation has been reported as a simple, inexpensive, non-invasive technique to speed recovery and improve outcomes for traumatic comatose patients. Methods/design: This multicentre, prospective, randomised (1:1) controlled trial aims to demonstrate the efficacy and safety of electrical right median nerve stimulation (RMNS) in both accelerating emergence from coma and promoting long-term outcomes. This trial aims to enrol 380 TBI comatose patients to partake in either an electrical stimulation group or a non-stimulation group. Patients assigned to the stimulation group will receive RMNS in addition to standard treatment at an amplitude of 15-20 mA with a pulse width of 300 μs at 40 Hz ON for 20 s and OFF for 40 s. The electrical treatment will last for 8 h per day for 2 weeks. The primary endpoint will be the percentage of patients regaining consciousness 6 months after injury. The secondary endpoints will be Extended Glasgow Outcome Scale, Coma Recovery Scale-Revised and Disability Rating Scale scores at 28 days, 3 months and 6 months after injury; Glasgow Coma Scale, Glasgow Coma Scale Motor Part and Full Outline of Unresponsiveness scale scores on day 1 and day 7 after enrolment and 28 days, 3 months and 6 months after injury; duration of unconsciousness and mechanical ventilation; length of intensive care unit and hospital stays; and incidence of adverse events. Discussion: Right median nerve electrical stimulation has been used as a safe, inexpensive, non-invasive therapy for neuroresuscitation of coma patients for more than two decades, yet no trial has robustly proven the efficacy and safety of this treatment. The Asia Coma Electrical Stimulation (ACES) trial has the following novel features compared with other major RMNS trials: (1) the ACES trial is an Asian multicentre randomised controlled trial; (2) RMNS therapy starts at an early stage 7-14 days after the injury; and (3) various assessment scales are used to evaluate the condition of patients. We hope the ACES trial will lead to optimal use of right median nerve electrical treatment. Trial registration: ClinicalTrials.gov, NCT02645578 . Registered on 23 December 2015.

Acute Traumatic Coma Awakening Induced by Median Nerve Electrical Stimulation: A Systematic Review and Meta-Analysis

Acute Traumatic Coma Awakening by Right Median Nerve Electrical Stimulation: a Randomised Controlled Trial

Electroencephalogram (EEG) With or Without Transcranial Magnetic Stimulation (TMS) as Biomarkers for Post-stroke Recovery: A Narrative Review

Right Median Nerve Electrical Stimulation for Acute Traumatic Coma Patients

Nomogram for Early Prediction of Outcome in Coma Patients with Severe Traumatic Brain Injury Receiving Right Median Nerve Electrical Stimulation Treatment.

Parameters of Median Nerve Electrical Stimulation for Coma after Traumatic Brain Injury

Clinical Efficacy of Early Right Median Nerve Electrical Stimulation for Coma Patients Followingcraniocerebral Trauma

MicroRNA alteration in cerebrospinal fluid from comatose patients with traumatic brain injury after right median nerve stimulation

Clinical study on median nerve stimulation therapy in improving the level of consciousness of patients in coma caused by head traumas

Efficacy of median nerve electrical stimulation on the recovery of patients with consciousness disorders: a systematic review and meta-analysis

Primary Study on Median Nerve Stimulation Therapy in Improving the Level of Consciousness of Patients in Coma Caused by Head Traumas

Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial

[Research progress on median nerve electrical stimulation for awakening comatose patients with brain injury]

Wake-promoting actions of median nerve stimulation in TBI-induced coma: An investigation of orexin-A and orexin receptor 1 in the hypothalamic region

Median Nerve Stimulation Attenuates Traumatic Brain Injury-Induced Comatose State by Regulating the Orexin-A/RasGRF1 Signaling Pathway

Effect of Right Median Nerve Electric Stimulation on Brain Electrical Activity of Traumatic Coma Patients

The Effectiveness of Non-Invasive Brain Stimulation on Arousal and Alertness in Patients in Coma or Persistent Vegetative State after Traumatic Brain Injury

Effect of median nerve electrical stimulation on expression of α1-adrenergic receptor in prefrontal cortex of coma rats induced by traumatic brain injury

Effect of Transcranial Direct Current Combined with Mirror Neuronal Rehabilitation Training System in Post-Traumatic Unconscious Patients with Severe Craniocerebral Injury

The Effectiveness of Non-Invasive Brain Stimulation on Arousal and Alertness in Patients in Coma or Persistent Vegetative State after Traumatic Brain Injury Protocol of Systematic Review and Network Meta-Analysis

Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury-induced coma: orexin-A-mediated N-methyl-D-aspartate receptor subunit NR1 upregulation